Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has…
- Homepage
- North America
- North America Legal Chronicle
- BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Tagged: 7-15-2026 Adam Gomes-Abreu Adam Hustad Alyssa Scruggs Amber Harezlak Amicus Therapeutics Amy Tong Andrea Rosato Andrew Levine BioMarin Pharmaceutical Inc. Brian King Cameron Smith Cem Albayrak Chad Crowell Chadé Severin Daniel Kirksey Daniel Rosenthal Dennis Williams Ethan Kirner Graham Robinson Grant Bilinovich Jackie Orfield Jennifer Lee Jennifer Leserman Joe Krisko John Kabealo John Ryan Isaacson John Sheridan Jones Day Jonn Beeson Julianne Turner Justin Coddington Kelsie Harris Kirkland & Ellis Lara Pillay Lucille Hague Mari Stonebraker Maria Raptis Matthew Kelley megadeals Olivia Chilcott Olivia Hunter Olivia Kaufmann Rachael Lichman Samantha Morelli Seth Traxler Shellie Weisfield Freedman Sophia Hudson Stefan Atkinson Timothy Nelson William Pruitt William Richmond
Author: Leila Ahmed
…